Asset Management One Co. Ltd. grew its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,405 shares of the biopharmaceutical company’s stock after acquiring an additional 1,027 […]
Allspring Global Investments Holdings LLC decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 18.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,889 shares of the biopharmaceutical company’s stock after selling 6,492 shares during the period. Allspring Global Investments Holdings […]
LPL Financial LLC raised its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,710 shares of the biopharmaceutical company’s stock after acquiring an additional 925 shares during the quarter. LPL Financial […]
Quintet Private Bank Europe S.A. purchased a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,520 shares of the biopharmaceutical company’s stock, valued at approximately $505,000. Other institutional investors also recently added […]
Connor Clark & Lunn Investment Management Ltd. boosted its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 940.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,901 shares of the biopharmaceutical company’s stock after purchasing an additional 11,661 […]